Anna M. Czarnecka

Citata da

	Tutte	Dal 2020
Citazioni	6137	3936
Indice H	42	32
i10-index	135	101

960

480

240

720

200720082009201020112012201320142015201620172018201920202021202220232024202528 58 78 119 89 93 114 141 176 227 278 349 397 496 677 843 801 941 159

Accesso pubblico

Visualizza tutto

25 articoli

2 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Ewa BartnikProfessor of Genetics, University of WarsawEmail verificata su igib.uw.edu.pl
wojtek KukwaMedical University of WarsawEmail verificata su wum.edu.pl
Michał FiedorowiczMossakowski Medical Research Centre, PASEmail verificata su imdik.pan.pl
Bożena Cybulska-StopaNarodowy Instytut Onkologii (NIO)Email verificata su vp.pl
Francesco CappelloProfessore Ordinario di Istologia, Università degli Studi di Palermo, Palermo, ItalyEmail verificata su unipa.it
Zofia Felicja BieleckaResearch Fellow, Military Institute of Medicine in WarsawEmail verificata su wim.mil.pl
Mohammed I. KhanPostdoctoral Scholar, Department of Otolaryngology-Head & Neck Surgery (OHNS), Stanford UniversityEmail verificata su stanford.edu
Pawel Golikprofessor, University of WarsawEmail verificata su igib.uw.edu.pl
Jacek MackiewiczUniwersytet Medyczny w PoznaniuEmail verificata su ump.edu.pl
Camillo PortaTranslational Oncology, IRCCS Istituti Clinici Scientifici MaugeriEmail verificata su icsmaugeri.it
Lukasz SzymanskiInstitute of Genetics and Animal Biotechnology, Polish Academy of SciencesEmail verificata su igbzpan.pl
Sławomir Lewicki, PhDInstitute of Genetics and Animal Biotechnology, Polish Academy of SciencesEmail verificata su igbzpan.pl
John A. PetrosProfessor of Urology, Emory UniversityEmail verificata su emory.edu
Fabio BucchieriFull Professor in Human Anatomy, University of PalermoEmail verificata su unipa.it
Jerzy S. CzarneckiSenior Lecturer, Łódź University, PolandEmail verificata su uni.lodz.pl
Valentina Di FeliceUniversità degli studi di PalermoEmail verificata su community.unipa.it
Jan LubinskiPomeranian Medical Univeristy in SzczecinEmail verificata su pum.edu.pl
Krzysztof BoguszMedical University of WarsawEmail verificata su student.wum.edu.pl
Magdalena KowalewskaCentrum Onkologii-InstytutEmail verificata su coi.pl
Krzysztof J. FilipiakUM MCS Warsaw, Uczelnia Medyczna im. Marii Skłodowskiej-Curie w WarszawieEmail verificata su uczelniamedyczna.com.pl

Segui

Anna M. Czarnecka

Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

Email verificata su coi.pl - Home page

melanoma cancer stem cells immunotherapy sarcoma renal cell cancer


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
Molecular Biology of Osteosarcoma AM Czarnecka, K Synoradzki, W Firlej, E Bartnik, P Sobczuk, ... Cancers 12 (8), 2130, 2020	303	2020
Choosing the right cell line for renal cell cancer research KK Brodaczewska, C Szczylik, M Fiedorowicz, C Porta, AM Czarnecka Molecular Cancer 15 (1), 83, 2016	300	2016
Mitochondrial chaperones in cancer: from molecular biology to clinical diagnostics AM Czarnecka, C Campanella, G Zummo, F Cappello Cancer biology & therapy 5 (7), 714-720, 2006	193	2006
Targeted Therapy in Melanoma and Mechanisms of Resistance AM Czarnecka, E Bartnik, M Fiedorowicz, P Rutkowski International Journal of Molecular Sciences 21 (13), 4576, 2020	182	2020
The role of the cell–cell interactions in cancer progression K Kamińska, C Szczylik, ZF Bielecka, E Bartnik, C Porta, F Lian, ... Journal of cellular and molecular medicine 19 (2), 283-296, 2015	150	2015
Three‐dimensional cell culture model utilization in cancer stem cell research ZF Bielecka, K Maliszewska‐Olejniczak, IJ Safir, C Szczylik, ... Biological Reviews 92 (3), 1505-1520, 2017	146	2017
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from … L D’Ambrosio, N Touati, JY Blay, G Grignani, R Flippot, AM Czarnecka, ... Cancer 126 (11), 2637-2647, 2020	131	2020
Mitochondrial DNA mutations in human neoplasia AM Czarnecka, P Golik, E Bartnik Journal of applied genetics 47 (1), 67-78, 2006	130	2006
Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: From the patient's bed to molecular mechanisms M Buczek, B Escudier, E Bartnik, C Szczylik, A Czarnecka Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1845 (1), 31-41, 2014	120	2014
Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland AM Czarnecka, T Krawczyk, M Zdrożny, J Lubiński, RS Arnold, W Kukwa, ... Breast cancer research and treatment 121 (2), 511-518, 2010	116	2010
The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis A Myszczyszyn, AM Czarnecka, D Matak, L Szymanski, F Lian, ... Stem Cell Reviews and Reports 11 (6), 919-943, 2015	95	2015
Rhabdomyosarcoma of the head and neck in children J Radzikowska, W Kukwa, A Kukwa, A Czarnecka, A Krzeski Contemporary Oncology 19 (2), 98-107, 2015	95	2015
Mechanisms of acquired resistance to tyrosine kinase inhibitors in clear-cell renal cell carcinoma (ccRCC) Z F Bielecka, A M Czarnecka, W Solarek, A Kornakiewicz, C Szczylik Current signal transduction therapy 8 (3), 219-228, 2013	85	2013
Heat shock protein 10 and signal transduction: a “capsula eburnea” of carcinogenesis? AM Czarnecka, C Campanella, G Zummo, F Cappello Cell stress & chaperones 11 (4), 287, 2006	80	2006
Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells MI Khan, AM Czarnecka, I Helbrecht, E Bartnik, F Lian, C Szczylik Stem Cell Research & Therapy 6 (1), 178, 2015	79	2015
Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches (Review) MI Khan, ZF Bielecka, MZ Najm, E Bartnik, JS Czarnecki, AM Czarnecka, ... International journal of oncology 44 (2), 349-363, 2014	79	2014
Upon oxidative stress, the antiapoptotic Hsp60/procaspase-3 complex persists in mucoepidermoid carcinoma cells C Campanella, F Bucchieri, NM Ardizzone, A Marino Gammazza, ... European Journal of Histochemistry 52 (4), 221-228, 2009	73	2009
Insulin-like growth factor-1 signaling in renal cell carcinoma AF Tracz, C Szczylik, C Porta, AM Czarnecka BMC cancer 16 (1), 453, 2016	68	2016
Insulin and IGFs in renal cancer risk and progression W Solarek, AM Czarnecka, B Escudier, ZF Bielecka, F Lian, C Szczylik Endocrine-related cancer 22 (5), R253-R264, 2015	68	2015
The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: from nature to laboratory. MI Khan, AA Sobocińska, AM Czarnecka, M Król, B Botta, C Szczylik Current pharmaceutical design, 2015	67	2015

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori